AAP

Aussies wait 15 months longer than US, Europe for drugs

DRUG companies are delaying making cancer-fighting drugs and other medicines available to Australian patients because of the smaller domestic market, a new report has found.

The latest review of the Therapeutic Goods Administration has found patients are waiting up to 15 months longer than those in the United States or Europe for some drugs.

While the report said some companies had complained the TGA's processes took longer, the independent review showed approvals took an average 90 days to complete.

Among the drugs cited for unusually long waits were anti-cancer medications, at five months; cardiovascular medicines, at seven months, and some nervous system medicines, at up to 15 months.

Health Minister Sussan Ley said the review "debunks the myth that Australia is slow at approving new medicines when compared to the rest of the world".

Rather, some drugs firms were just testing new drugs first in the larger markets.


Temperatures set to drop below average in parts of region

Premium Content Temperatures set to drop below average in parts of region

Brrr – there’s going to be some cold mornings this week.

Jobs on offer ahead of 2021 Australian Census

Premium Content Jobs on offer ahead of 2021 Australian Census

The Australian Bureau of Statistics is currently recruiting to help deliver the...

Elderly residents left traumatised by road rage

Premium Content Elderly residents left traumatised by road rage

‘So traumatised that she will not go out again’: Ballina Shire Council to address...